Back

Genomic analyses identify key molecules and significant signaling pathways in Sorafenib treated hepatocellular cancer cells

Chang, T.; Wang, M.

2022-03-18 bioinformatics
10.1101/2022.03.15.484435 bioRxiv
Show abstract

Sorafenib (Sfb) is a multikinase inhibitor that is significantly effective in killing liver cancer. However, the potential signaling pathways and mechanisms remain unknown. Here, we aim to identify the functional molecules and signaling pathways by analyzing the RNA-seq data. The GSE186280 was produced by the Illumina HiSeq 2000 (Homo sapiens). The KEGG and GO analyses indicated the MAPK signaling pathway and transcriptional misregulation in cancer are the major signaling pathways during the treatment of Sfb in liver cancer. Moreover, we identified ten key molecules including TP53, MYC, ACTB, CREBBP, HSP90AA1, JUN, UBB, SIRT1, CCNA2, RBX1. Therefore, this study provides novel knowledge of Sfb treated liver cancer.

Matching journals

The top 15 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.